News | April 01, 2026
Rusan unveils APOSAN 3ml multi-dose pen
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The investigational new drug application with FDA was actually for NEOK002, an EGFR/MUC1-targeting antibody-drug conjugate aimed at solid tumors
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
As Tracky launches integrated health solution
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Subscribe To Our Newsletter & Stay Updated
